The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | Sauvage Philippe | Chief Financial Officer | Option exercise(M) | 48K | $2.17 | $103K |
| Jun 23, 2026 | Sauvage Philippe | Chief Financial Officer | Sell(S) | 48K | $6.01 | $286K |
| Jun 23, 2026 | Sauvage Philippe | Chief Financial Officer | Option exercise(M) | 48K | — | $0 |
| Jun 23, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | Option exercise(M) | 90K | $1.87 | $169K |
| Jun 23, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | Option exercise(M) | 35K | $1.74 | $60K |
| Jun 23, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | Sell(S) | 125K | $6.03 | $753K |
| Jun 23, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | Option exercise(M) | 90K | — | $0 |
| Jun 23, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | Option exercise(M) | 35K | — | $0 |
| Jun 23, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Option exercise(M) | 63K | $2.93 | $185K |
| Jun 23, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell(S) | 63K | $6.02 | $379K |
| Jun 23, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Option exercise(M) | 63K | — | $0 |
| Jun 9, 2026 | Mashal Robert | Director | Buy(P) | 25K | $4.73 | $118K |
| May 21, 2026 | Blickenstaff Kim D | Director | Grant(A) | 123K | — | $0 |
| May 21, 2026 | Bazemore Robert B | Director | Grant(A) | 123K | — | $0 |
| May 21, 2026 | Falberg Kathryn E | Director | Grant(A) | 123K | — | $0 |
| May 21, 2026 | Cui Xiangmin | Director | Grant(A) | 123K | — | $0 |
| May 21, 2026 | Mashal Robert | Director | Grant(A) | 123K | — | $0 |
| May 21, 2026 | Vernon W Anthony | Director | Grant(A) | 123K | — | $0 |
| Apr 17, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Option exercise(M) | 37K | $2.93 | $108K |
| Apr 17, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell(S) | 37K | $5.01 | $184K |
| Apr 17, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Option exercise(M) | 37K | — | $0 |
| Apr 17, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 50K | $1.94 | $97K |
| Apr 17, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell(S) | 50K | $5.02 | $251K |
| Apr 17, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 50K | — | $0 |
| Apr 6, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Option exercise(M) | 100K | $1.87 | $187K |
| Apr 6, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Option exercise(M) | 100K | $1.94 | $194K |
| Apr 6, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell(S) | 200K | $4.52 | $904K |
| Apr 6, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Option exercise(M) | 100K | — | $0 |
| Apr 6, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Option exercise(M) | 100K | — | $0 |
| Feb 27, 2026 | Hung David | PRESIDENT AND CEO, Director, 10% Owner | Grant(A) | 2.0M | — | $0 |
| Feb 27, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Grant(A) | 748K | — | $0 |
| Feb 27, 2026 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Grant(A) | 748K | — | $0 |
| Feb 27, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | Grant(A) | 748K | — | $0 |
| Feb 27, 2026 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Grant(A) | 748K | — | $0 |
| Feb 27, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | Grant(A) | 748K | — | $0 |
| Feb 27, 2026 | Makunje Moses | SEE REMARKS | Grant(A) | 51K | — | $0 |
| Feb 27, 2026 | Makunje Moses | SEE REMARKS | Grant(A) | 224K | — | $0 |
| Feb 27, 2026 | Sjogren Colleen | Chief Commercial Officer | Grant(A) | 748K | — | $0 |
| Feb 27, 2026 | Sauvage Philippe | Chief Financial Officer | Grant(A) | 748K | — | $0 |
| Feb 27, 2026 | Cui Xiangmin | Director | Grant(A) | 77K | — | $0 |
| Dec 1, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 150K | $2.93 | $440K |
| Dec 1, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell(S) | 150K | $7.82 | $1.2M |
| Dec 1, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 150K | — | $0 |
| Nov 26, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell(S) | 10K | $8.00 | $80K |
| Nov 26, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 10K | $3.61 | $36K |
| Nov 26, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 10K | — | $0 |
| Nov 25, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell(S) | 10K | $7.50 | $75K |
| Nov 25, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 10K | $3.61 | $36K |
| Nov 25, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 10K | — | $0 |
| Nov 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 69K | $1.74 | $120K |
| Nov 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell(S) | 69K | $7.23 | $499K |
| Nov 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 300K | $1.94 | $582K |
| Nov 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell(S) | 300K | $7.23 | $2.2M |
| Nov 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 69K | — | $0 |
| Nov 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 300K | — | $0 |
| Nov 20, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 20K | $1.87 | $37K |
| Nov 20, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell(S) | 20K | $7.00 | $140K |
| Nov 20, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 20K | — | $0 |
| Nov 19, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Option exercise(M) | 200K | $1.87 | $374K |
| Nov 19, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Sell(S) | 200K | $7.14 | $1.4M |
| Nov 19, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Option exercise(M) | 200K | — | $0 |
| Nov 19, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 15K | $1.87 | $28K |
| Nov 19, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell(S) | 15K | $5.10 | $77K |
| Nov 19, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 15K | — | $0 |
| Nov 17, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 15K | $1.87 | $28K |
| Nov 17, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell(S) | 15K | $4.77 | $72K |
| Nov 17, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 15K | — | $0 |
| Oct 27, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell(S) | 100K | $5.02 | $502K |
| Oct 27, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 100K | $1.74 | $174K |
| Oct 27, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 100K | — | $0 |
| Aug 11, 2025 | Mashal Robert | Director | Gift(G) | 350K | — | $0 |
| Aug 11, 2025 | Mashal Robert | Director | Gift(G) | 350K | — | $0 |
| Jun 18, 2025 | Markel Stacy | CHIEF PEOPLE OFFICER | Buy(P) | 10K | $1.71 | $17K |
| Jun 17, 2025 | Sauvage Philippe | Chief Financial Officer | Buy(P) | 4K | $1.79 | $7K |
| Jun 16, 2025 | Hung David | PRESIDENT AND CEO, Director, 10% Owner | Buy(P) | 500K | $1.79 | $895K |
| Jun 16, 2025 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Buy(P) | 24K | $1.80 | $43K |
| Jun 16, 2025 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Buy(P) | 26K | $1.79 | $47K |
| Jun 16, 2025 | Sjogren Colleen | Chief Commercial Officer | Buy(P) | 50K | $1.81 | $91K |
| Jun 16, 2025 | Sauvage Philippe | Chief Financial Officer | Buy(P) | 3K | $1.84 | $6K |
| May 21, 2025 | Bazemore Robert B | Director | Grant(A) | 293K | — | $0 |
| May 21, 2025 | Blickenstaff Kim D | Director | Grant(A) | 293K | — | $0 |
| May 21, 2025 | Falberg Kathryn E | Director | Grant(A) | 293K | — | $0 |
| May 21, 2025 | Mashal Robert | Director | Grant(A) | 293K | — | $0 |
| May 21, 2025 | Vernon W Anthony | Director | Grant(A) | 293K | — | $0 |
| May 2, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell(S) | 20K | $2.50 | $50K |
| May 2, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 20K | $1.94 | $39K |
| May 2, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Option exercise(M) | 20K | $1.94 | $39K |
| Apr 7, 2025 | Hung David | PRESIDENT AND CEO, Director, 10% Owner | Buy(P) | 300K | $1.63 | $489K |
| Apr 4, 2025 | Hung David | PRESIDENT AND CEO, Director, 10% Owner | Buy(P) | 200K | $1.66 | $332K |
| Apr 1, 2025 | Mashal Robert | Director | Buy(P) | 99K | $1.67 | $165K |
| Apr 1, 2025 | Mashal Robert | Director | Buy(P) | 1K | $1.67 | $2K |
| Feb 28, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Grant(A) | 500K | — | $0 |
| Feb 28, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Grant(A) | 500K | — | $0 |
| Feb 28, 2025 | Hung David | PRESIDENT AND CEO, Director, 10% Owner | Grant(A) | 2.0M | — | $0 |
| Feb 28, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Grant(A) | 500K | — | $0 |
| Feb 28, 2025 | Makunje Moses | SEE REMARKS | Grant(A) | 250K | — | $0 |
| Feb 28, 2025 | Markel Stacy | CHIEF PEOPLE OFFICER | Grant(A) | 500K | — | $0 |
| Feb 28, 2025 | Sauvage Philippe | Chief Financial Officer | Grant(A) | 500K | — | $0 |
| Feb 28, 2025 | Sjogren Colleen | Chief Commercial Officer | Grant(A) | 500K | — | $0 |
| Feb 28, 2025 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Grant(A) | 500K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).